Cytotoxic chemotherapeutic agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy19

T-Lymphocytes, Cytotoxic Cell Line, Tumor Tumor Cells, Cultured Cell Line Cells, Cultured HCT116 Cells K562 Cells HL-60 Cells Neoplastic Stem Cells HT29 Cells Clone Cells KB Cells HeLa Cells Mitochondria T-Lymphocytes Killer Cells, Natural MCF-7 Cells Hep G2 Cells Spleen

Organisms8

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Adenoviridae Mice, Inbred C3H Mice, Inbred Strains Rats, Nude

Diseases29

Neoplasms Breast Neoplasms Lung Neoplasms Neoplasms, Experimental Colonic Neoplasms Ovarian Neoplasms Melanoma Brain Neoplasms Pancreatic Neoplasms Leukemia Adenocarcinoma Glioma Leukemia L1210 Osteosarcoma Liver Neoplasms Prostatic Neoplasms Glioblastoma Carcinoma, Hepatocellular Colorectal Neoplasms Neuroblastoma Melanoma, Experimental Carcinoma, Non-Small-Cell Lung Disease Models, Animal Carcinoma Lymphoma Mammary Neoplasms, Experimental Neoplasm Metastasis Bone Neoplasms Carcinoma, Squamous Cell

Chemicals and Drugs125

Antineoplastic Agents Doxorubicin Cisplatin Antineoplastic Agents, Phytogenic Paclitaxel Antibiotics, Antineoplastic Etoposide Fluorouracil Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic P-Glycoprotein Vincristine Deoxycytidine Proto-Oncogene Proteins c-bcl-2 Tumor Suppressor Protein p53 Carmustine Cyclophosphamide Dacarbazine Camptothecin Mitomycin Caspases Vinblastine Daunorubicin Pore Forming Cytotoxic Proteins Methotrexate Taxoids Cytotoxins Melphalan Apoptosis Regulatory Proteins Noscapine RNA, Small Interfering Neoplasm Proteins Caspase 3 Enzyme Inhibitors Poly(ADP-ribose) Polymerases Thioguanine bcl-X Protein Bleomycin Cytarabine Hycanthone Prodrugs Mitoxantrone Lomustine Antibodies, Monoclonal Tubulin Modulators bcl-2-Associated X Protein Radiation-Sensitizing Agents Organoplatinum Compounds Tetrazolium Salts RNA, Messenger Multidrug Resistance-Associated Proteins Alkylating Agents Plant Extracts Mechlorethamine Carboplatin Drug Carriers Nitrosourea Compounds Nitrogen Mustard Compounds TNF-Related Apoptosis-Inducing Ligand Cardiotoxins Topotecan Topoisomerase II Inhibitors Arsenicals Isocoumarins Pyrazines Membrane Glycoproteins Boronic Acids NF-kappa B Proto-Oncogene Proteins c-akt Floxuridine 6-Mercaptopurine Mitomycins Proto-Oncogene Proteins ATP-Binding Cassette Transporters Gossypol Protein Kinase Inhibitors Topoisomerase I Inhibitors Nitroimidazoles Tilorone DNA Indoles Recombinant Proteins DNA, Neoplasm DNA Topoisomerases, Type II Piperazines Reactive Oxygen Species Inhibitor of Apoptosis Proteins Xanthones Antigens, Neoplasm Thymidylate Synthase Receptors, TNF-Related Apoptosis-Inducing Ligand Triterpenes Amsacrine Glutathione Dactinomycin Platinum Tumor Necrosis Factor-alpha Antiprotozoal Agents Granzymes DNA-Binding Proteins Immunotoxins Thiazoles Cytostatic Agents Guanine Naphthoquinones Dimetridazole Oxides Perforin O(6)-Methylguanine-DNA Methyltransferase Anthracyclines Caspase 7 Oligonucleotides, Antisense Trypanocidal Agents Stilbenes X-Linked Inhibitor of Apoptosis Protein Angiogenesis Inhibitors Topoisomerase Inhibitors Formazans Myeloid Cell Leukemia Sequence 1 Protein Curcumin Protein-Serine-Threonine Kinases Zinostatin Quinazolines Nuclear Proteins Cyclin-Dependent Kinase Inhibitor p21

Analytical, Diagnostic and Therapeutic Techniques and Equipment34

Drug Screening Assays, Antitumor Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Inhibitory Concentration 50 Neoplasm Transplantation Neoplasms, Experimental Flow Cytometry Drug Delivery Systems Blotting, Western Drug Evaluation, Preclinical Combined Modality Therapy Transfection Transplantation, Heterologous Cytotoxicity Tests, Immunologic Tumor Stem Cell Assay Reverse Transcriptase Polymerase Chain Reaction Drug Carriers Drug Administration Schedule Tumor Burden Immunotherapy Treatment Outcome Immunohistochemistry Clinical Trials as Topic Melanoma, Experimental Genetic Therapy In Situ Nick-End Labeling Disease Models, Animal Colony-Forming Units Assay Drug Design Mammary Neoplasms, Experimental Models, Biological Molecular Targeted Therapy Immunoblotting Lymphocyte Activation

Phenomena and Processes41

Drug Resistance, Neoplasm Apoptosis Cell Survival Drug Synergism Drug Resistance, Multiple Dose-Response Relationship, Drug Cell Proliferation Cytotoxicity, Immunologic Inhibitory Concentration 50 Cell Cycle DNA Damage Cell Division Cell Death Gene Expression Regulation, Neoplastic Drug Resistance Time Factors Signal Transduction Transfection Down-Regulation DNA Repair Molecular Structure Enzyme Activation Up-Regulation Drug Interactions Cell Growth Processes DNA Fragmentation RNA Interference Genes, p53 Gene Expression Phosphorylation Genes, MDR Amino Acid Sequence Mutation Base Sequence Kinetics Genetic Vectors Cell Cycle Checkpoints G2 Phase Membrane Potential, Mitochondrial Convection Lymphocyte Activation

Disciplines and Occupations3

Immunohistochemistry Nanomedicine Drug Design

Technology, Industry, Agriculture2

Nanomedicine Nanoparticles

Information Science3

Molecular Sequence Data Amino Acid Sequence Base Sequence

Health Care2

Treatment Outcome Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Antineoplastic Agents T-Lymphocytes, Cytotoxic Doxorubicin Cell Line, Tumor Drug Resistance, Neoplasm Apoptosis Cisplatin Cell Survival Drug Synergism Antineoplastic Agents, Phytogenic Drug Screening Assays, Antitumor Tumor Cells, Cultured Paclitaxel Antibiotics, Antineoplastic Neoplasms Etoposide Drug Resistance, Multiple Fluorouracil Antineoplastic Agents, Alkylating Dose-Response Relationship, Drug Antineoplastic Combined Chemotherapy Protocols Antimetabolites, Antineoplastic Xenograft Model Antitumor Assays Cell Proliferation Mice, Nude Cytotoxicity, Immunologic Inhibitory Concentration 50 P-Glycoprotein Vincristine Cell Cycle Deoxycytidine Breast Neoplasms Proto-Oncogene Proteins c-bcl-2 Tumor Suppressor Protein p53 DNA Damage Carmustine Cyclophosphamide Dacarbazine Camptothecin Neoplasm Transplantation Mitomycin Lung Neoplasms Cell Division Caspases Vinblastine Daunorubicin Cell Death Cell Line Gene Expression Regulation, Neoplastic Mice, Inbred BALB C Pore Forming Cytotoxic Proteins Neoplasms, Experimental Flow Cytometry Methotrexate Drug Resistance Drug Delivery Systems Colonic Neoplasms Blotting, Western Time Factors Taxoids Cytotoxins Drug Evaluation, Preclinical Melphalan Combined Modality Therapy Signal Transduction Transfection Ovarian Neoplasms Transplantation, Heterologous Apoptosis Regulatory Proteins Noscapine RNA, Small Interfering Neoplasm Proteins Caspase 3 Enzyme Inhibitors Poly(ADP-ribose) Polymerases Thioguanine bcl-X Protein Bleomycin Cytarabine Melanoma Hycanthone Down-Regulation Prodrugs Mice, SCID Mice, Inbred C57BL Mitoxantrone Cells, Cultured Brain Neoplasms Lomustine Antibodies, Monoclonal Tubulin Modulators bcl-2-Associated X Protein Cytotoxicity Tests, Immunologic HCT116 Cells Radiation-Sensitizing Agents Organoplatinum Compounds Tetrazolium Salts RNA, Messenger Multidrug Resistance-Associated Proteins DNA Repair

No FAQ available that match "cytotoxic chemotherapeutic agents"